MARKET analysts at Datamonitor
have forecast that Novartis will
deliver the strongest prescription
drug sales growth of all Big
Pharma’s for the period 2009 - 2015.
The prediction, based on its
annual “organic performance”,
foresees that the company will have
an annual growth rate of 4% which
would result in around $10 billion
in sales.
Conversely, Datamonitor analysts
have forecast an average annual
growth rate for Big Pharma in
general of 1.4%.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jul 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jul 10
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.